Post by Solvias
22,778 followers
Could hantaviruses become a concern for biopharmaceuticals? With a recent hantavirus outbreak making headlines, it's a timely question. In this week's Thursday Thoughts, our CSO Daniel Galbraith discusses what these viruses are, whether they could pose a risk to biopharmaceutical manufacturing, and what the industry should be thinking about as new viral threats emerge. Interested in learning more about viral safety? Watch our webinar, NGS Adoption for Viral Safety: From Experimental Tool to Regulatory-Endorsed Standard, to explore how next-generation sequencing is transforming viral safety testing. Watch here: https://lnkd.in/e5_MWNgA #ThursdayThoughts #Hantavirus #ViralSafety #NGS #Biosafety
Video Content